Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
Compounding Pharmacy is widely used for consumers aged 18 and younger, consumers aged 19 to 44, consumers aged 45 to 64, consumers aged 65 and older. The most proportion of compounding pharmacy is consumers aged 45 to 64, and the proportion in 2018 is 40.3%.
Americas is the largest market for compounding pharmacy, with a market share nearly 60.5% in 2018. Following America, Europe is the second largest market with the consumption market share of 25.5%.

According to this study, over the next five years the Compounding Pharmacy market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 12000 million by 2024, from US$ 10600 million in 2019. In particular, this report presents the global revenue market share of key companies in Compounding Pharmacy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Compounding Pharmacy market by product type, application, key companies and key regions.

This study considers the Compounding Pharmacy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
PIA
PAA
PDA
SAPM
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Fagron
CAPS
Wedgewood Pharma
NewCo Pharma GmbH
PharMEDium Services
Advanced Pharma
Dougherty?s Pharmacy
Institutional Pharmacy Solutions
Triangle Compounding Pharmacy
Olympia Pharmacy
Lorraine?s Pharmacy
Village Compounding Pharmacy

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Compounding Pharmacy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Compounding Pharmacy market by identifying its various subsegments.
Focuses on the key global Compounding Pharmacy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Compounding Pharmacy with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Compounding Pharmacy submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.